Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Ba

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Cell Death & Disease|May 10, 2018
MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathwayWu Sun, Xiaojun Wang, Jialu Li, et al.
Japanese Journal of Clinical Oncology|January 29, 2016
Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapyJingjing Duan, Ting Deng, Guoguang Ying, et al.
Nutrition and Cancer|February 12, 2019
Nutritional Risk Assessment by Scored Patient-Generated Subjective Global Assessment Associated with Demographic Characteristics in 23,904 Common Malignant Tumors PatientsChunhua Song, Jingjing Cao, Feng Zhang, et al.
Oncogene|June 18, 2021
The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancerHuiya Wang, Xia Wang, Haiyang Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 24, 2016
MGMT in colorectal cancer: a promising component of personalized treatmentLe Zhang, Jing Zeng, Zhaolei Zeng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 7, 2017
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinomaRui Liu, Haiyang Zhang, Yan Zhang, et al.
Cell Death & Disease|November 30, 2021
Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cellsHaiyang Zhang, Meng Wang, Yi He, et al.
Cancer Letters|September 26, 2025
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib studyMing Bai, Ning Li, Xianli Yin, et al.
Science Translational Medicine|April 9, 2025
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcriptsXiaoqiang Wang, Jiaxing Jin, Han Yan, et al.
Investigational New Drugs|October 27, 2023
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trialTing Deng, Le Zhang, Yehui Shi, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Cell Death & Disease|May 10, 2018
MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathwayWu Sun, Xiaojun Wang, Jialu Li, et al.
Japanese Journal of Clinical Oncology|January 29, 2016
Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapyJingjing Duan, Ting Deng, Guoguang Ying, et al.
Nutrition and Cancer|February 12, 2019
Nutritional Risk Assessment by Scored Patient-Generated Subjective Global Assessment Associated with Demographic Characteristics in 23,904 Common Malignant Tumors PatientsChunhua Song, Jingjing Cao, Feng Zhang, et al.
Oncogene|June 18, 2021
The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancerHuiya Wang, Xia Wang, Haiyang Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 24, 2016
MGMT in colorectal cancer: a promising component of personalized treatmentLe Zhang, Jing Zeng, Zhaolei Zeng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 7, 2017
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinomaRui Liu, Haiyang Zhang, Yan Zhang, et al.
Cell Death & Disease|November 30, 2021
Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cellsHaiyang Zhang, Meng Wang, Yi He, et al.
Cancer Letters|September 26, 2025
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib studyMing Bai, Ning Li, Xianli Yin, et al.
Science Translational Medicine|April 9, 2025
The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcriptsXiaoqiang Wang, Jiaxing Jin, Han Yan, et al.
Investigational New Drugs|October 27, 2023
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trialTing Deng, Le Zhang, Yehui Shi, et al.
Pageof 21